Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Gemini Therapeutics, Inc. (GMTX) Investigation By: Bronstein, Gewirtz & Grossman, LLC via Business Wire February 21, 2023 at 12:36 PM EST Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FS Development Corp., which merged with Gemini Therapeutics, Inc. ("Gemini" or "the Company") (NASDAQ: GMTX) on February 5, 2021. Such investors who continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/gmtx. The investigation concerns whether FS Development Corp. failed to provide relevant information to its shareholders before the merger. If you are aware of any facts relating to this investigation or hold Gemini shares, you can assist this investigation by visiting the firm’s site: www.bgandg.com/gmtx. You can also contact Peretz Bronstein or his Law Clerk and Clients Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes. View source version on businesswire.com: https://www.businesswire.com/news/home/20230221005714/en/Contacts Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Nathanson 212-697-6484 | info@bgandg.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Gemini Therapeutics, Inc. (GMTX) Investigation By: Bronstein, Gewirtz & Grossman, LLC via Business Wire February 21, 2023 at 12:36 PM EST Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FS Development Corp., which merged with Gemini Therapeutics, Inc. ("Gemini" or "the Company") (NASDAQ: GMTX) on February 5, 2021. Such investors who continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/gmtx. The investigation concerns whether FS Development Corp. failed to provide relevant information to its shareholders before the merger. If you are aware of any facts relating to this investigation or hold Gemini shares, you can assist this investigation by visiting the firm’s site: www.bgandg.com/gmtx. You can also contact Peretz Bronstein or his Law Clerk and Clients Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes. View source version on businesswire.com: https://www.businesswire.com/news/home/20230221005714/en/Contacts Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Nathanson 212-697-6484 | info@bgandg.com
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FS Development Corp., which merged with Gemini Therapeutics, Inc. ("Gemini" or "the Company") (NASDAQ: GMTX) on February 5, 2021. Such investors who continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/gmtx. The investigation concerns whether FS Development Corp. failed to provide relevant information to its shareholders before the merger. If you are aware of any facts relating to this investigation or hold Gemini shares, you can assist this investigation by visiting the firm’s site: www.bgandg.com/gmtx. You can also contact Peretz Bronstein or his Law Clerk and Clients Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes. View source version on businesswire.com: https://www.businesswire.com/news/home/20230221005714/en/
